Clavulanic Acid
Clavulanic acid is a beta-lactamase inhibitor. It blocks certain bacterial enzymes that can break down amoxicillin, allowing the penicillin-like antibiotic to remain active against susceptible bacteria. Every attached record pairs the two ingredients.
Key points
- Clavulanic acid is a beta-lactamase inhibitor, not a standalone catalogue antibiotic.
- Augmentin contains amoxicillin with 125 mg clavulanic acid.
- Advent DT records amoxicillin with 57 mg clavulanic acid.
- Allergy and prior liver reactions are central combination-specific cautions.
Augmentin spans three strength pairs
Augmentin represents 250 mg plus 125 mg, 500 mg plus 125 mg, and 875 mg plus 125 mg tablets. It connects with sinusitis, otitis media and broader bacterial infections.
The clavulanic acid amount stays at 125 mg in all three recorded pairs while the amoxicillin amount changes. Reading the pair together prevents a two-ingredient medicine from being treated as a single strength.
Advent DT is a separate pair
Advent DT records 400 mg amoxicillin with 57 mg clavulanic acid. Both products belong to antibiotics, but the attached strength pair and brand identity are distinct.
Official information says the combination acts against bacteria, not viral infections. A history of serious penicillin or cephalosporin allergy, or liver problems previously caused by amoxicillin-clavulanic acid, is particularly important. Severe or persistent diarrhoea also has a recognised antibiotic safety context.